These results go in line with the prognostic relevance of the CD3+ and CD8+ T-cell infiltration in the tumor and the invasive tumor margin in colon cancer, where patients with a high immunoscore show the lowest 5-year disease recurrence (32). The gene discussed is CD8A; the disease is malignant colon neoplasm.